On 2024-03-27, Vaxxinity, Inc. (VAXX) announced earnings per share of $-0.09 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.13.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-03-27 | 2023-12-31 | $-0.13 | $-0.09 |
| 2023-11-08 | 2023-09-30 | $-0.14 | $-0.10 |
| 2023-08-09 | 2023-06-30 | $-0.16 | $-0.11 |
| 2023-05-09 | 2023-03-31 | $-0.16 | $-0.15 |
| 2023-03-27 | 2022-12-31 | $-0.16 | $-0.16 |
| 2022-11-10 | 2022-09-30 | $-0.16 | $-0.15 |
| 2022-08-11 | 2022-06-30 | $-0.38 | $-0.14 |
| 2022-05-09 | 2022-03-31 | $-0.34 | $-0.31 |
| 2022-03-24 | 2021-12-31 | $-0.35 | $-0.48 |
| 2021-12-23 | 2021-09-30 | $-0.12 | $-0.44 |